Corporate Finance Deal Review 2023

A Reflection of 2023

Since 2020 it’s felt like there has been one challenge after another for businesses across all sectors. 2023 was no different with many enterprises feeling the effects of soaring inflation and interest rate rises. This latter point often has a significant direct impact on the merger and acquisition market, with many reporting a slowing down during the year.

With rates appearing to have now peaked and expectations of reductions later in 2024, coupled with substantial cash reserves amongst large corporates and sound credit market appetite, there are some encouraging signs for 2024.


Deal Review

Despite the market challenges facing businesses in 2023, our Corporate Finance team had a strong year completing 16 deals with a total value of £67,214,748. This enabled us to grow our team to increase our service capacity as we look forward in 2024.

Pete Wilmer

Senior Partner

2023 in a Snapshot

Number of deals advised on




Employee Ownership Trusts

Share Buy-back

Our Top 3 Sectors

In 2023, we saw strong activity in the manufacturing and the healthcare & pharmaceutical sectors.

We also closed deals for businesses operating in the financial services sector as well as technology and agriculture.

  • Manufacturing 37.5% 37.5%
  • Healthcare & Pharmaceuticals 37.5% 37.5%
  • Financial Services 12.5% 12.5%

Total value of deals

Outlook for 2024

2024 looks set to be a solid year for merger and acquisition activity as more confidence returns to the market following the calming of inflation and interest rates.

Our outlook on the market suggests another strong year for merger and acquisitions in the manufacturing sector as well as an increased number of Employee Ownership Trust transactions.

Our Corporate Finance Team

Pete Wilmer

Senior Partner
Jack Ware, Corporate Finance Director

Jack Ware

Corporate Finance Director
Jack Parker, Corporate Finance Manager
Jack Parker

Corporate Finance Manager